Rajesh C. Shrotriya's most recent trade in GT Biopharma Inc was a trade of 500,000 Option to purchase Common Stock done . Disclosure was reported to the exchange on Jan. 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GT Biopharma Inc | Rajesh C. Shrotriya | Director | 27 Jan 2023 | 500,000 | 500,000 | - | - | Option to purchase Common Stock | ||
| GT Biopharma Inc | Rajesh C. Shrotriya | Director | 15 Jul 2022 | 361,476 | 361,476 | - | - | Option to purchase Common Stock | ||
| GT Biopharma Inc | Rajesh C. Shrotriya | Director | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | ||
| GT Biopharma Inc | Rajesh C. Shrotriya | Director | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock | ||
| CASI Pharmaceuticals Inc | Rajesh C. Shrotriya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 345,806 | 345,806 | - | - | Stock Option (Right to Buy) |